Update on the development of molecular imaging and nanomedicine in China: Optical imaging
Update on the development of molecular imaging and nanomedicine in China: Optical imaging
复制标题
中国分子影像和纳米医学发展最新动态：光学成像
DOI：
10.1002/wnan.1660
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Sun Xilin
中科院分区：
文献类型：
--
作者：
Wu Lina;Zou Hongyan;Wang Hongbin;Zhang Sihang;Liu Shuang;Jiang Ying;Chen Jing;Li Yingbo;Shao Mengping;Zhang Ruixin;Li Xiaona;Dong Jing;Yang Lili;Wang Kai;Zhu Xinyuan;Sun Xilin
分子影像学在世界范围内受到越来越多的关注，包括在中国，因为它提供了广泛多样的临床重要病理学的非侵入性表征。为了实现这些目标，纳米医学已经发展成为一个广泛的跨学科领域，具有灵活的设计，通过选择性结合疾病特异性细胞膜生物标志物，将成像和治疗有效载荷容纳并集中到病理细胞中。这种个性化医疗的概念反映了100多年前德国生物化学家保罗埃利希提出的“灵丹妙药”的愿景。正如世界各地发生的那样，中国科学家正在通过有影响力的国家项目和国际研究合作为这场科技海啸做出贡献。这篇综述提供了中国创新的全面更新，以解决中国和世界各地在光学科学方面难以满足的医疗需求。这篇文章分类下：诊断工具>体内纳米诊断和成像
Molecular imaging has received increased attention worldwide, including in China, because it offers noninvasive characterization of widely diverse clinically significant pathologies. To achieve these goals, nanomedicine has evolved into a broad interdisciplinary field with flexible designs to accommodate and concentrate imaging and therapeutic payloads into pathological cells through selective binding to disease specific cell membrane biomarkers. This concept of personalized medicine reflects the vision of “magic bullets” proposed by German biochemist Paul Ehrlich over 100 years ago. As happening worldwide, Chinese scientists are contributing to this tsunami of science and technologies through impactful national programs and international research collaborations. This review provides a comprehensive update of Chinese innovations to address intractable unmet medical need in China and worldwide in the optical sciences.This article is categorized under:Diagnostic Tools > in vivo Nanodiagnostics and Imaging